Post-earnings recap
Reported
Thu, Nov 10, 2022
Est. EPS
—
Est. revenue
—
Implied move
—
EPS beat rate
88%
—
Est. EPS
—
Est. Rev
—
Impl. Move
—
CorMedix Inc. reported a narrower-than-expected loss per share, which led to a positive stock reaction, with shares rising by 9.19%. However, there was no revenue reported or guidance provided, leaving investors with limited insight into future performance. The stock's increase suggests that investors are optimistic about the company's ability to manage costs or improve its financial position.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $-0.17 | N/A | +26.09% |
| Revenue | N/A | N/A | N/A |
No transcript is on record, and the analysis is based on numerical results only.